$CSPCY · CSPC Pharmaceutical Group Limited Congress Trades

Rep. Josh Gottheimer (NJ-05) executed 49 transactions in a Morgan Stanley Select UMA account between September 6-26, 2023, consisting primarily of sales across a diversified portfolio of stocks including technology (GOOG, AAPL, NVDA, TSLA), healthcare (LLY, MRNA, DXCM), financials (MA, FIS), and consumer names (SBUX, TGT, STARBUCKS), with most positions valued at $1,001-$15,000 and one larger position in Dominion Energy (D) valued at $15,001-$50,000.

Rep. Josh Gottheimer (NJ-05) executed a high-volume portfolio rebalancing in July 2023, trading approximately 60+ stocks through a Morgan Stanley Select UMA account with mostly mixed buys and sells of large-cap tech, pharma, and international stocks, each in the $1,001-$15,000 range.

Rep. Josh Gottheimer (NJ-05) executed 45 transactions in June 2023 through a Morgan Stanley Select UMA account, with a mix of purchases and partial sales across major tech, financial, and industrial stocks. All transactions were in the $1,001-$15,000 range, including buys of Adobe, Broadcom, Meta, Shopify, Netflix, and Microsoft, alongside sales of Apple, NVIDIA, Tesla, Oracle, and numerous other holdings.

Rep. Josh Gottheimer made 12 transactions in a Morgan Stanley Select UMA Account during December 2022, involving purchases and partial sales of pharmaceutical and healthcare stocks including Amgen, ADP, Blackstone, Eli Lilly, Fidelity National Information Services, HaloZyme, Insmed, Pharmaceutical GRP, Ritchie Bros., Shoals Technologies, Supernus Pharmaceuticals, and Syneos Health, with all transactions valued between $1,001-$15,000.